Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference.
Kotecha D., Breithardt G., Camm AJ., Lip GYH., Schotten U., Ahlsson A., Arnar D., Atar D., Auricchio A., Bax J., Benussi S., Blomstrom-Lundqvist C., Borggrefe M., Boriani G., Brandes A., Calkins H., Casadei B., Castellá M., Chua W., Crijns H., Dobrev D., Fabritz L., Feuring M., Freedman B., Gerth A., Goette A., Guasch E., Haase D., Hatem S., Haeusler KG., Heidbuchel H., Hendriks J., Hunter C., Kääb S., Kespohl S., Landmesser U., Lane DA., Lewalter T., Mont L., Nabauer M., Nielsen JC., Oeff M., Oldgren J., Oto A., Pison L., Potpara T., Ravens U., Richard-Lordereau I., Rienstra M., Savelieva I., Schnabel R., Sinner MF., Sommer P., Themistoclakis S., Van Gelder IC., Vardas PE., Verma A., Wakili R., Weber E., Werring D., Willems S., Ziegler A., Hindricks G., Kirchhof P.
There are major challenges ahead for clinicians treating patients with atrial fibrillation (AF). The population with AF is expected to expand considerably and yet, apart from anticoagulation, therapies used in AF have not been shown to consistently impact on mortality or reduce adverse cardiovascular events. New approaches to AF management, including the use of novel technologies and structured, integrated care, have the potential to enhance clinical phenotyping or result in better treatment selection and stratified therapy. Here, we report the outcomes of the 6th Consensus Conference of the Atrial Fibrillation Network (AFNET) and the European Heart Rhythm Association (EHRA), held at the European Society of Cardiology Heart House in Sophia Antipolis, France, 17-19 January 2017. Sixty-two global specialists in AF and 13 industry partners met to develop innovative solutions based on new approaches to screening and diagnosis, enhancing integration of AF care, developing clinical pathways for treating complex patients, improving stroke prevention strategies, and better patient selection for heart rate and rhythm control. Ultimately, these approaches can lead to better outcomes for patients with AF.